Terms: = Sarcomas AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Clinical Outcome
7 results:
1. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract] [Full Text] [Related]
2. Gene expression-based prediction of pazopanib efficacy in sarcoma.
Heilig CE; Laßmann A; Mughal SS; Mock A; Pirmann S; Teleanu V; Renner M; Andresen C; Köhler BC; Aybey B; Bauer S; Siveke JT; Hamacher R; Folprecht G; Richter S; Schröck E; Brandts CH; Ahrens M; Hohenberger P; Egerer G; Kindler T; Boerries M; Illert AL; von Bubnoff N; Apostolidis L; Jost PJ; Westphalen CB; Weichert W; Keilholz U; Klauschen F; Beck K; Winter U; Richter D; Möhrmann L; Bitzer M; Schulze-Osthoff K; Brors B; Mechtersheimer G; Kreutzfeldt S; Heining C; Lipka DB; Stenzinger A; Schlenk RF; Horak P; Glimm H; Hübschmann D; Fröhling S
Eur J Cancer; 2022 Sep; 172():107-118. PubMed ID: 35763870
[TBL] [Abstract] [Full Text] [Related]
3. clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue sarcomas.
O'Sullivan Coyne G; Kummar S; Hu J; Ganjoo K; Chow WA; Do KT; Zlott J; Bruns A; Rubinstein L; Foster JC; Juwara L; Meehan R; Piekarz R; Streicher H; Sharon E; Takebe N; Voth AR; Bottaro D; Costello R; Wright JJ; Doroshow JH; Chen AP
Clin Cancer Res; 2022 Jan; 28(2):279-288. PubMed ID: 34716194
[TBL] [Abstract] [Full Text] [Related]
4. Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis.
Wang L; Sun Y; Zhao B; Zhang H; Yu Q; Yuan X
Oncotarget; 2016 Aug; 7(34):55732-55740. PubMed ID: 27248177
[TBL] [Abstract] [Full Text] [Related]
5. Src activity is increased in gastrointestinal stromal tumors--analysis of associations with clinical and other molecular tumor characteristics.
Rotert JV; Leupold J; Hohenberger P; Nowak K; Allgayer H
J Surg Oncol; 2014 May; 109(6):597-605. PubMed ID: 24391050
[TBL] [Abstract] [Full Text] [Related]
6. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774
[TBL] [Abstract] [Full Text] [Related]
7. Expression of vascular endothelial growth factor and its receptor, kdr/Flk-1, in soft tissue sarcomas.
Pakos EE; Goussia AC; Tsekeris PG; Papachristou DJ; Stefanou D; Agnantis NJ
Anticancer Res; 2005; 25(5):3591-6. PubMed ID: 16101185
[TBL] [Abstract] [Full Text] [Related]
